Page last updated: 2024-10-26

diethylcarbamazine and Hypereosinophilic Syndrome

diethylcarbamazine has been researched along with Hypereosinophilic Syndrome in 2 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kothari, SS1
Deepti, S1
Rai, N1
Andy, JJ1
Ekott, JU1
Ansa, VO1

Other Studies

2 other studies available for diethylcarbamazine and Hypereosinophilic Syndrome

ArticleYear
Reversible bioprosthetic valve thrombosis from eosinophilia.
    BMJ case reports, 2018, Feb-08, Volume: 2018

    Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Diethylcarbamazine; Echocardiography; Heart Valve Pr

2018
Systemic thromboembolism in endomyocardial fibrosis (EMF): clinical observations, aetio-pathogenesis and treatment.
    African journal of medicine and medical sciences, 2010, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Echocardiography; Endomyocardial Fibrosis; Female; F

2010